CIRSE | September 14th - 18th | Lisbon, Portugal |Room 1.11
Unleash your potential with Lipiodol® Ultra Fluid
and become glue confident: MEET THE EXPERTS
Monday, Sept 16th 10:00 - 11:00 (WEST)
GET GLUE CONFIDENT! Hands-on workshop
Prof. Romaric Loffroy
University of Burgundy.
Dijon, France.
Dr. Bernhard Meyer
Hannover Medical School.
Hannover, Germany.
Saturday, Sept 14th 14:00 - 15:00 (WEST)
Glue in vascular embolization
Prof. Romaric Loffroy
University of Burgundy.
Dijon, France.
Monday, Sept 16th 15:00 - 16:00 (WEST)
Prostate artery embolization
with glue
Dr. Clare Bent
University Hospitals Dorset.
Bournemouth, United Kingdom.
Sunday, Sept 15th 14:00 - 15:00 (WEST)
Variceal and Non-Variceal Bleeding
Prof. Anna Maria Ierardi
University of Milan, Milan, Italy.
Tuesday, Sept 17th 14:00 - 15:00 (WEST)
Pelvic vein embolization with glue
Prof. José Urbano
Ramon y Cajal University Hospital.
Madrid, Spain.
IMMERSE YOURSELF IN THE CATH-LAB
Experience Cath-Lab prostate artery embolization through virtual glasses with Dr. Aaron Fischman.Every day on booth #69 from 09:30 to 17:00 (WEST) depending on availability
For the SmPC, please ask a representative on the booth.
This information is intended for an international audience or is provided during
an international event. Lipiodol® Ultra Fluid (Ethyl esters of iodized fatty acids
of poppy seed oil) is not registered in all countries. Be aware that Indications,
posology, and presentations may differ from country to country. For current
and complete prescribing information refer to the local Summary of Product
Characteristics (SmPC) and /or contact your local Guerbet organization.
RCM local disponível no stand.
Esta informação destina-se a um público internacional ou é fornecida durante um
evento internacional. O Lipiodol® Ultra Fluído (ésteres etílicos de ácidos gordos
iodados de óleo de sementes de papoila) não está registado em todos os países
pelo que a sua posologia e as apresentações podem diferir de país para país.
Para mais informações por favor consultar o RCM local e/ou o titular de AIM.